本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Karyopharm Therapeutics Inc.

8.00
-0.1600-1.96%
成交量:45.16萬
成交額:360.94萬
市值:1.80億
市盈率:-0.45
高:8.24
開:8.16
低:7.81
收:8.16
52周最高:10.99
52周最低:3.65
股本:2,254.33萬
流通股本:2,139.52萬
量比:0.65
換手率:2.11%
股息:- -
股息率:- -
每股收益(TTM):-17.9300
每股收益(LYR):-17.9300
淨資產收益率:-891.05%
總資產收益率:-41.56%
市淨率:-0.62
市盈率(LYR):-0.45

資料載入中...

2021/02/17

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

重要事件披露

8-K - Current report
2021/01/27

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/11

重要事件披露

8-K - Current report
2020/12/18

重要事件披露

8-K - Current report
2020/12/17

重要事件披露

8-K - Current report
2020/12/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/01

重要事件披露

8-K - Current report
2020/11/02

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/02

重要事件披露

8-K - Current report
2020/09/25

重要事件披露

8-K - Current report
2020/08/31

重要事件披露

8-K - Current report
2020/08/04

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans